These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 34484239)

  • 21. T-CoV: a comprehensive portal of HLA-peptide interactions affected by SARS-CoV-2 mutations.
    Nersisyan S; Zhiyanov A; Shkurnikov M; Tonevitsky A
    Nucleic Acids Res; 2022 Jan; 50(D1):D883-D887. PubMed ID: 34396391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predicting population coverage of T-cell epitope-based diagnostics and vaccines.
    Bui HH; Sidney J; Dinh K; Southwood S; Newman MJ; Sette A
    BMC Bioinformatics; 2006 Mar; 7():153. PubMed ID: 16545123
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunogenic T cell epitopes of SARS-CoV-2 are recognized by circulating memory and naïve CD8 T cells of unexposed individuals.
    Quiros-Fernandez I; Poorebrahim M; Fakhr E; Cid-Arregui A
    EBioMedicine; 2021 Oct; 72():103610. PubMed ID: 34627082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening HLA-A-restricted T cell epitopes of SARS-CoV-2 and the induction of CD8
    Jin X; Ding Y; Sun S; Wang X; Zhou Z; Liu X; Li M; Chen X; Shen A; Wu Y; Liu B; Zhang J; Li J; Yang Y; Qiu H; Shen C; He Y; Zhao G
    Cell Mol Immunol; 2021 Dec; 18(12):2588-2608. PubMed ID: 34728796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A promiscuous T cell epitope-based HIV vaccine providing redundant population coverage of the HLA class II elicits broad, polyfunctional T cell responses in nonhuman primates.
    Ribeiro SP; De Moura Mattaraia VG; Almeida RR; Valentine EJG; Sales NS; Ferreira LCS; Sa-Rocha LC; Jacintho LC; Santana VC; Sidney J; Sette A; Rosa DS; Kalil J; Cunha-Neto E
    Vaccine; 2022 Jan; 40(2):239-246. PubMed ID: 34961636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immuno-informatics design of a multimeric epitope peptide based vaccine targeting SARS-CoV-2 spike glycoprotein.
    Chukwudozie OS; Gray CM; Fagbayi TA; Chukwuanukwu RC; Oyebanji VO; Bankole TT; Adewole RA; Daniel EM
    PLoS One; 2021; 16(3):e0248061. PubMed ID: 33730022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD8 T cell epitope generation toward the continually mutating SARS-CoV-2 spike protein in genetically diverse human population: Implications for disease control and prevention.
    Guo E; Guo H
    PLoS One; 2020; 15(12):e0239566. PubMed ID: 33301503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design of an epitope-based peptide vaccine against the SARS-CoV-2: a vaccine-informatics approach.
    Alam A; Khan A; Imam N; Siddiqui MF; Waseem M; Malik MZ; Ishrat R
    Brief Bioinform; 2021 Mar; 22(2):1309-1323. PubMed ID: 33285567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Promiscuous
    Scholzen A; Richard G; Moise L; Baeten LA; Reeves PM; Martin WD; Brauns TA; Boyle CM; Raju Paul S; Bucala R; Bowen RA; Garritsen A; De Groot AS; Sluder AE; Poznansky MC
    Front Immunol; 2019; 10():207. PubMed ID: 30828331
    [No Abstract]   [Full Text] [Related]  

  • 30. HLArestrictor--a tool for patient-specific predictions of HLA restriction elements and optimal epitopes within peptides.
    Erup Larsen M; Kloverpris H; Stryhn A; Koofhethile CK; Sims S; Ndung'u T; Goulder P; Buus S; Nielsen M
    Immunogenetics; 2011 Jan; 63(1):43-55. PubMed ID: 21079948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Three Specific Potential Epitopes That Could Be Recognized by T Cells of Convalescent COVID-19 Patients Were Identified From Spike Protein.
    Zhang Y; Yang Z; Tang M; Li H; Tang T; Li G; Zhong Y; Zhang X; Wang X; Wang C
    Front Immunol; 2022; 13():752622. PubMed ID: 35154095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD8
    Qiu C; Xiao C; Wang Z; Zhu G; Mao L; Chen X; Gao L; Deng J; Su J; Su H; Fang EF; Zhang ZJ; Zhang J; Xie C; Yuan J; Luo OJ; Huang LA; Wang P; Chen G
    Front Immunol; 2021; 12():764949. PubMed ID: 35116022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and validation of 174 COVID-19 vaccine candidate epitopes reveals low performance of common epitope prediction tools.
    Prachar M; Justesen S; Steen-Jensen DB; Thorgrimsen S; Jurgons E; Winther O; Bagger FO
    Sci Rep; 2020 Nov; 10(1):20465. PubMed ID: 33235258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of HLA-A2 restricted CD8
    Deng J; Pan J; Qiu M; Mao L; Wang Z; Zhu G; Gao L; Su J; Hu Y; Luo OJ; Chen G; Wang P
    J Leukoc Biol; 2021 Dec; 110(6):1171-1180. PubMed ID: 34231935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs.
    Weingarten-Gabbay S; Klaeger S; Sarkizova S; Pearlman LR; Chen DY; Gallagher KME; Bauer MR; Taylor HB; Dunn WA; Tarr C; Sidney J; Rachimi S; Conway HL; Katsis K; Wang Y; Leistritz-Edwards D; Durkin MR; Tomkins-Tinch CH; Finkel Y; Nachshon A; Gentili M; Rivera KD; Carulli IP; Chea VA; Chandrashekar A; Bozkus CC; Carrington M; ; Bhardwaj N; Barouch DH; Sette A; Maus MV; Rice CM; Clauser KR; Keskin DB; Pregibon DC; Hacohen N; Carr SA; Abelin JG; Saeed M; Sabeti PC
    Cell; 2021 Jul; 184(15):3962-3980.e17. PubMed ID: 34171305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel, in-natural-infection subdominant HIV-1 CD8+ T-cell epitopes revealed in human recipients of conserved-region T-cell vaccines.
    Borthwick N; Lin Z; Akahoshi T; Llano A; Silva-Arrieta S; Ahmed T; Dorrell L; Brander C; Murakoshi H; Takiguchi M; Hanke T
    PLoS One; 2017; 12(4):e0176418. PubMed ID: 28448594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mapping the SARS-CoV-2 spike glycoprotein-derived peptidome presented by HLA class II on dendritic cells.
    Parker R; Partridge T; Wormald C; Kawahara R; Stalls V; Aggelakopoulou M; Parker J; Powell Doherty R; Ariosa Morejon Y; Lee E; Saunders K; Haynes BF; Acharya P; Thaysen-Andersen M; Borrow P; Ternette N
    Cell Rep; 2021 May; 35(8):109179. PubMed ID: 34004174
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SARS-CoV-2-Seronegative Subjects Target CTL Epitopes in the SARS-CoV-2 Nucleoprotein Cross-Reactive to Common Cold Coronaviruses.
    Schmidt KG; Nganou-Makamdop K; Tenbusch M; El Kenz B; Maier C; Lapuente D; Überla K; Spriewald B; Bergmann S; Harrer EG; Harrer T
    Front Immunol; 2021; 12():627568. PubMed ID: 33995351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD8
    Murakoshi H; Zou C; Kuse N; Akahoshi T; Chikata T; Gatanaga H; Oka S; Hanke T; Takiguchi M
    Retrovirology; 2018 Jul; 15(1):46. PubMed ID: 29970102
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of Novel Candidate CD8
    Pushpakumara PD; Madhusanka D; Dhanasekara S; Jeewandara C; Ogg GS; Malavige GN
    Viruses; 2021 May; 13(6):. PubMed ID: 34073934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.